|
RCM
|
R1 RCM Inc.
|
0.03%
|
US
|
NASDAQ
|
|
PHR
|
Phreesia, Inc.
|
0.03%
|
US
|
NYSE
|
|
ZNTL
|
Zentalis Pharmaceuticals, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
VIVO
|
Meridian Bioscience Inc.
|
0.02%
|
US
|
NASDAQ
|
|
VCEL
|
Vericel Corporation
|
0.02%
|
US
|
NASDAQ
|
|
USPH
|
U.S. Physical Therapy, Inc.
|
0.02%
|
US
|
NYSE
|
|
TWST
|
Twist Bioscience Corporation
|
0.02%
|
US
|
NASDAQ
|
|
TVTX
|
Travere Therapeutics, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
TGTX
|
TG Therapeutics, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
SNDX
|
Syndax Pharmaceuticals, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
SDGR
|
Schrodinger, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
SAVA
|
Cassava Sciences, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
RYTM
|
Rhythm Pharmaceuticals, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
RVMD
|
Revolution Medicines, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
RETA
|
Reata Pharmaceuticals, Inc. - Class A
|
0.02%
|
US
|
NASDAQ
|
|
REPL
|
Replimune Group, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
RDNT
|
RadNet, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
RCKT
|
Rocket Pharmaceuticals, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
QURE
|
uniQure N.V.
|
0.02%
|
US
|
NASDAQ
|
|
NXGN
|
NextGen Healthcare, Inc.
|
0.02%
|
US
|
NASDAQ
|